Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cynthia Voong"'
Autor:
Lipika Goyal, Cesar Augusto Perez, Shumei Kato, Manish Sharma, Benjamin Garmezy, Ken Kobayashi, Aleksandra Franovic, Betty Tam, Cynthia Voong
Publikováno v:
Journal of Clinical Oncology. 40:TPS9601-TPS9601
TPS9601 Background: FGFR1-4 gene alterations are observed in approximately 7% of all human cancers. There are currently 3 FDA-approved, reversible FGFRi for treatment of patients w/previously treated, locally advanced or metastatic (met) cholangiocar
Autor:
Naiyer A. Rizvi, Thomas Boucher, Elie Fadel, Christine D. Palmer, Andrew Clark, Matthew J. Davis, Vladimir Makarov, John Hrom, Mark G. Frattini, Niki Karachaliou, Timothy A. Chan, Michele Busby, Kamilah Caldwell, Mojca Skoberne, Jennifer Busby, Karin Choquette, Ian Anderson, Joshua M. Francis, Jesse Abhyankar, Meghan G. Hart, Vincent Thomas de Montpréville, Olaf Mercier, Raphael Rousseau, Karin Jooss, Paolo Bironzo, Aaron Yang, Alexander I. Spira, Rafael Rosell, Tyler Murphy, Fujiko Duke, Roman Yelensky, Noelle C Ojo, Lauren Young, Chainarong Limvarapuss, Giorgio V. Scagliotti, Nashat Gabrail, Brendan Bulik-Sullivan, Cynthia Voong, Silvia Novello
Publikováno v:
Nature biotechnology.
Neoantigens, which are expressed on tumor cells, are one of the main targets of an effective antitumor T-cell response. Cancer immunotherapies to target neoantigens are of growing interest and are in early human trials, but methods to identify neoant
Autor:
Mojca Skoberne, Raphael Rousseau, Jennifer Busby, Brendan Bulik, Naiyer A. Rizvi, Karin Jooss, Aaron Yang, Mark Frattini, Joshua M. Francis, Rita Zhou, Matthew M. Davis, Meghan G. Hart, Cynthia Voong, Andrew Clark, Lauren Young, Kamilah Caldwell, Tyler Murphy, Fujiko Duke, Roman Yelensky, Mike Zhong, Jesse Abhyankar, Christine D. Palmer, Alison Cook, Thomas Boucher
Publikováno v:
Cancer Research. 79:4059-4059
Immune Checkpoint Blockade (ICB) has revolutionized the treatment of patients with cancer but provides durable clinical benefit to only a minority of patients. Neoantigens, antigens derived from tumor mutations, are emerging as key targets of T cells
Autor:
Mitch Raponi, Tone Ikdahl, Cynthia Voong, Andrew R. Allen, Stefan Boeck, Volker Heinemann, Claudio Bassi, T.R. Jeffry Evans, Jeffrey D. Isaacson, Harpreet Wasan, Volodymyr Bondar, Elizabeth Poplin, I. Bondarenko, Paramjit Kaur, Irina Davidenko, Lindsey Rolfe, August Garin
Publikováno v:
Journal of Clinical Oncology. 31:4007-4007
4007 Background: Gemcitabine requires membrane transporter proteins to cross the cell membrane. Low expression of the human equilibrative nucleoside transporter-1 (hENT1) may play a role in gemcitabine resistance in PDAC. CO-101 (also known as CP-412
Autor:
Andrew R. Allen, Cynthia Voong, Mitch Raponi, Tone Ikdahl, E. Tomasetto, S. Jones, L. Smith, Irina Davidenko, Claudio Bassi, Lindsey Rolfe, Jeffrey D. Isaacson, Elizabeth Poplin, S. McLachlan
Publikováno v:
Journal of Clinical Oncology. 29:TPS144-TPS144
TPS144 Background: Gemcitabine (Gem) is standard of care therapy for mPDAC, however many patients do not benefit. Gem requires a transporter protein, hENT1, to enter cells. Reduced tumor hENT1 expr...
Autor:
Poplin E; Elizabeth Poplin, Cancer Institute of New Jersey, New Brunswick, NJ; Mitch Raponi, Elaina Mann, Cynthia Voong, and Andrew Allen, Clovis Oncology, San Francisco, CA; Hejin Hahn and Vince Picozzi, Virginia Mason Medical Center, Seattle, WA; Adam Dicker, Radiation Therapy Oncology Group, Philadelphia, PA; Jeff Isaacson, Clovis Oncology, Boulder, CO; Harpreet Wasan, Hammersmith Hospital, London; Lindsey Rolfe and Paramjit Kaur, Clovis Oncology UK, Cambridge; T.R. Jeffrey Evans, University of Glasgow, Glasgow, United Kingdom; Tone Ikdahl, Oslo Universitetssykehus, Oslo, Norway; Ihor Bondarenko, Dnipropetrovsk State Medical Academy, Dnipropetrovsk; Volodymyr Bondar, Donetsk Regional Antitumor Center, Donetsk, Ukraine; Irina Davidenko, Clinical Oncology Center 1, Krasnodar; August Garin, Blokhin Russian Cancer Research Center, Moscow, Russia; Stefan Boeck, Steffen Ormanns, and Volker Heinemann, Ludwig-Maximilians-University of Munich, Munich, Germany; Claudio Bassi, Ospedale Policlinico G.B. Rossi, Verona, Italy; and Roland Andersson, Lund University, Lund, Sweden., Wasan H, Rolfe L, Raponi M, Ikdahl T, Bondarenko I, Davidenko I, Bondar V, Garin A, Boeck S, Ormanns S, Heinemann V, Bassi C, Evans TR, Andersson R, Hahn H, Picozzi V, Dicker A, Mann E, Voong C, Kaur P, Isaacson J, Allen A
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Dec 10; Vol. 31 (35), pp. 4453-61. Date of Electronic Publication: 2013 Nov 12.